Comparison of Rheumatoid Factor and anti-Cyclic-Citrullinated protein antibodies for the Diagnosis of rheumatic arthritis in Khartoum, Sudan

dc.contributor.authorShaaban Khudair
dc.contributor.authorMowahib Al Edressy
dc.contributor.authorMohammed Abbas
dc.contributor.authorAhmed Bolad
dc.date.accessioned2017-11-26T12:24:30Z
dc.date.available2017-11-26T12:24:30Z
dc.date.issued2014-12-22
dc.description.abstractBackground: The objective of the current study was to determine the sensitivity and specificity of anti-Cyclic-Citrullinated protein antibodies (anti-CCP antibodies) as compared to that of Rheumatoid Factor (RF) in diagnosing patients with rheumatoid arthritis (RA) Methodology Fifty six samples were collected from Sudanese patients (46 females, 9 males) with rheumatic diseases who visited the rheumatology clinic ElRibat Hospital, Khartoum, Sudan. Titers of RF and anti-CCP antibodies of each patient were recorded. Sensitivity and specificity of the test were evaluated using ELISA as the gold standard method. Results The sensitivity of (RF) test (41/56) was 73.2% whereas the sensitivity of Anti CCP test (34/56) was 60.7%. The specificity of RF test (44/56) was 78.6%, whereas the specificity of Anti CCP test (54/56) was 96.4%. Conclusions The combination of anti-CCP and RF tests provides nearly 100% and thus could be helpful in the differential diagnosis of RA and other rheumatic diseasesen_US
dc.identifier.urihttp://hdl.handle.net/123456789/8576
dc.publisherجامعة النيلين - كلية الدراسات العلياen_US
dc.subjectanti-CCP antibodiesen_US
dc.subjectRheumatoid Factoren_US
dc.titleComparison of Rheumatoid Factor and anti-Cyclic-Citrullinated protein antibodies for the Diagnosis of rheumatic arthritis in Khartoum, Sudanen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
page-123.pdf
Size:
29.94 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: